Holen Sie sich die Stockscreener-App
212.11
1.79%
-3.87
Handel nachbörslich:
212.50
0.39
+0.18%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt STE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$215.98
Offen:
$215.41
24-Stunden-Volumen:
1.39M
Relative Volume:
1.68
Marktkapitalisierung:
$20.80B
Einnahmen:
$5.94B
Nettoeinkommen (Verlust:
$785.30M
KGV:
26.73
EPS:
7.9343
Netto-Cashflow:
$972.40M
1W Leistung:
+2.25%
1M Leistung:
-4.24%
6M Leistung:
-17.92%
1J Leistung:
-14.08%
1-Tages-Spanne:
$211.32
$216.65
1-Wochen-Bereich:
$199.74
$216.65
52-Wochen-Spanne:
$195.14
$269.44
Steris Plc Stock (STE) Company Profile
Firmenname
Steris Plc
Sektor
Branche
Telefon
35312322000
Adresse
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
212.11 | 21.18B | 5.94B | 785.30M | 972.40M | 7.9343 |
ABT
Abbott Laboratories
|
84.47 | 147.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
306.76 | 117.12B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
76.15 | 98.82B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
52.68 | 79.59B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.38 | 46.84B | 6.30B | 1.07B | 1.09B | 1.8406 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-05-29 | Eingeleitet | Jefferies | Hold |
| 2024-10-24 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2023-05-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-04-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-23 | Herabstufung | Needham | Buy → Hold |
| 2022-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-07 | Eingeleitet | Wolfe Research | Outperform |
| 2021-05-26 | Hochstufung | Needham | Hold → Buy |
| 2021-02-04 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-09 | Eingeleitet | Needham | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2018-01-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-06-05 | Herabstufung | Wellington Shields | Gradually Accumulate → Hold |
| 2017-05-03 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2016-11-30 | Eingeleitet | Goldman | Neutral |
| 2016-06-03 | Hochstufung | Northcoast | Neutral → Buy |
| 2015-06-12 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2013-05-07 | Herabstufung | Griffin Securities | Buy → Hold |
| 2013-02-08 | Bestätigt | Griffin Securities | Buy |
| 2012-08-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2012-02-08 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2011-11-03 | Bestätigt | JMP Securities | Mkt Outperform |
| 2011-02-09 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-12-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2010-04-07 | Bestätigt | CL King | Strong Buy |
| 2010-03-26 | Eingeleitet | CL King | Strong Buy |
| 2010-03-03 | Eingeleitet | Brean Murray | Hold |
Alle ansehen
Steris Plc Aktie (STE) Neueste Nachrichten
Steris plc stock (IE00BFY8C754): steady growth story after latest earnings - AD HOC NEWS
STERIS Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: STERIS Q4 2026 sees strong revenue, EPS miss - Investing.com Nigeria
How Investors May Respond To STERIS (STE) Record FY26 Results And US$1 Billion Buyback Plan - simplywall.st
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
New STERIS (STE) director Pierre Boulud files initial Form 3 ownership report - Stock Titan
Steris bets big on Mentor with new $60M plant and U.S. consolidation plan - Crain's Cleveland Business
Steris plc stock (IE00BFY8C754): Shares up 1.41% to $230.46 on Jul 25 - AD HOC NEWS
Steris anticipates 7%-8% revenue growth and $11.10-$11.30 EPS in fiscal 2027 as board authorizes $1B buyback - MSN
Steris stock (IE00BFY8C754): Q4 earnings miss, analyst targets cut - AD HOC NEWS
STE Maintained by Keybanc -- Price Target Lowered to $269 - GuruFocus
KeyBanc cuts STERIS stock price target on lower peer multiples - Investing.com
KeyBanc cuts STERIS stock price target on lower peer multiples By Investing.com - Investing.com Nigeria
Stephens Adjusts Price Target on STERIS to $270 From $300, Maintains Overweight Rating - marketscreener.com
Jefferies Adjusts Price Target on STERIS to $225 From $253, Maintains Hold Rating - marketscreener.com
KeyBanc Adjusts Price Target on STERIS to $269 From $291, Maintains Overweight Rating - marketscreener.com
Steris stock (IE00BFY8C754): Q4 revenue beats but EPS misses guidance - AD HOC NEWS
Needham Maintains Steris PLC(STE.US) With Hold Rating - Moomoo
What To Expect From STERIS’s (STE) Q1 Earnings - Yahoo Finance UK
Higher Near-Term Revenue Forecasts and Expanding Margins Lift Steris' Fair Value Estimate - Morningstar
Steris PLC (STE) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook By GuruFocus - Investing.com Canada
STERIS Plc Experiences Valuation Adjustment Amid Competitive Pharmaceuticals Landscape - Markets Mojo
Piper Sandler Maintains Steris PLC(STE.US) With Buy Rating, Maintains Target Price $300 - Moomoo
Steris PLC (STE) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook - GuruFocus
Research Alert: CFRA Retains Buy Rating On Steris Plc - Moomoo
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading - TradingView
Earnings call transcript: STERIS Q4 2026 revenue beats, EPS misses slightly - Investing.com Nigeria
Earnings call transcript: STERIS Q4 2026 revenue beats, EPS misses slightly By Investing.com - Investing.com South Africa
State Street (STE) reports 5.1% stake in STERIS PLC in Schedule 13G - Stock Titan
STERIS climbs after full-year results, new $1B buyback, and upbeat FY2027 outlook - Quiver Quantitative
Steris 4Q Cont Ops EPS $2.24 >STE - Moomoo
Transcript: Steris Q4 2026 Earnings Conference Call - Benzinga
Q4 2026 STERIS plc Earnings Call Transcript - GuruFocus
STERIS plc Q4 2026 Earnings Call Summary - Yahoo Finance
Steris 4Q Adj EPS $2.83 >STE - Moomoo
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of STERIS plc (NYSE:STE) - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Acquires Shares of STERIS plc (NYSE:STE) - MarketBeat
Steris 4Q Rev $1.6B >STE - Moomoo
Research Alert: Steris Closes Fiscal 2026 With Solid Growth And Initiates Fy 27 Guidance - Moomoo
Steris Sees FY Adj EPS $11.10-Adj EPS $11.30 >STE - Moomoo
STERIS Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Fiscal 2027 Adjusted EPS Guidance - Moomoo
Steris forecasts 2027 profit above estimates, banks on procedure-driven demand - marketscreener.com
Is Steris (STE) 24.5% Undervalued After FY26 Q4? Adjusted EPS $2 - GuruFocus
Steris (STE) Q4 Earnings and Revenues Miss Estimates - Yahoo Finance
STERIS plc reports results for the quarter ended March 31Earnings Summary - TradingView
STERIS PLC (NYSE:STE) fiscal Q4 results beat EPS estimates, driving shares up 4% in after-hours trading - ChartMill
Steris PLC stock underperforms Monday when compared to competitors - MarketWatch
STERIS plc (STE) Stock Rises on Q4 2026 Earnings - Quiver Quantitative
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year - The Globe and Mail
(STE) STERIS Expects Fiscal 2027 Adjusted EPS Range $11.10$11.30, vs. FactSet Est of $11.10 - marketscreener.com
Earnings Flash (STE) STERIS plc Reports Q4 Revenue $1.59B, vs. FactSet Est of $1.59B - marketscreener.com
Finanzdaten der Steris Plc-Aktie (STE)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.59%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):